Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis
J. Huang (Dundee, United Kingdom), Y. Gao (Dundee, United Kingdom), A. Barton (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), H. Leyah (Dundee, United Kingdom), H. Barclay (Dundee, United Kingdom), E. Kuzmanova (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Huang (Dundee, United Kingdom), Y. Gao (Dundee, United Kingdom), A. Barton (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), H. Leyah (Dundee, United Kingdom), H. Barclay (Dundee, United Kingdom), E. Kuzmanova (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom). Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis. 324
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Sputum biomarkers in COPD exacerbations Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011
Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018
Sputum colour as a marker of acute bacterial exacerbations of COPD Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations Year: 2003
Sputum proteomics of CF, BE and COPD with or without NTM infections Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021
Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes Source: Eur Respir J 2015; 46: 688-696 Year: 2015
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003
Immunometabolic markers and the sputum microbiome in bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021
Prediction of imminent COPD exacerbations by sputum analysis Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003
The biology of pulmonary exacerbations in bronchiectasis Source: Eur Respir Rev, 28 (154) 190055; 10.1183/16000617.0055-2019 Year: 2019
Eosinophils: a biological marker for bronchiectasis exacerbations? Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019
Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020
Applications of induced sputum sampling in asthma and COPD Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013
Endotyping of COPD, bronchiectasis and their overlap syndrome by integrated sputum proteome/microbiome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis Source: Eur Respir J, 51 (5) 1702173; 10.1183/13993003.02173-2017 Year: 2018
Inflammatory markers in sputum of patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
The BAL in the bacteriologic etiology in the COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005
Sputum galactomannan in COPD patients with and without bronchiectasis Source: International Congress 2017 – Bronchial asthma management Year: 2017